AIM WINNERS & LOSERS: CelLBxHealth rises on Qiagen deal

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

CelLBxHealth PLC, up 7.2% at 1.93 pence, 12-month range 1.70p-2.70p. The liquid biopsy firm, focused on cancer treatment and diagnosis, enters into a deal with Qiagen NV. The deal mean sample and assay technologies firm Qiagen can provide CelLBxHealth’s Parsortix platform to its pharmaceutical partners. ‘Partnering with a global provider of assay technologies for molecular diagnostics, is illustrative of the company’s key focus in driving commercial progress,’ the AIM listing says. CelLBxHealth was formerly known as Angle.

----------

Vast Resources PLC, up 6.1% at 0.14 pence, 12-month range 0.065p-0.65p. The miner in Romania, Tajikistan and Zimbabwe rules out an equity fundraise. In a shareholder Q&A published on Tuesday, Vast says it ‘has no current intention of conducting a placing to satisfy’ a December 31 debt repayment.

----------

AIM - LOSERS

----------

Greatland Resources Ltd, down 4.2% at 363.00p, 12-month range 104.20p-435.00p. Shares in the gold producer track the precious metal price lower. Gold traded as low as $3,997.66 an ounce on Tuesday, off a record high of roughly $4,381 an ounce achieved last month. Gold had traded as high as around $4,101.15 on Monday.

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.